ß-amyloid amorphous aggregates induced by the small natural molecule ferulic acid

Bramanti E., Fulgentini L., Bizzarri R., Lenci F., Sgarbossa A.

Type
Papers in JCR/ISI journals
Year
2013
Journal
JOURNAL OF PHYSICAL CHEMISTRY B
Volume
117 (44)
Pages
13816–13821
Impact factor
3.377
Citations
40 (Web of Science, updated on 22 November 2026)
Keywords
Fibrils In-vitro; Alzheimers-disease; Thioflavin-t; Cross-linking; A-beta; Protein; Binding; Oligomers; Fibrillogenesis; Neurotoxicity

INO authors

Fulgentini Lorenzo

Abstract

There is an emerging interest in small natural molecules for their potential therapeutic use in neurodegenerative disorders like Alzheimer’s disease (AD). Ferulic acid (FA), an antioxidant phenolic compound present in fruit and vegetables, has been proposed as an inhibitor of beta amyloid (A beta) pathological aggregation. Using fluorescence and Fourier transform infrared spectroscopy, electrophoresis techniques, chromatographic analysis, and confocal microscopy, we investigated the effects of FA in the early stages of A beta fibrillogenesis in vitro. Our results show that FA interacts promptly with A beta monomers/oligomers, interfering since the beginning with its self-assembly and finally forming amorphous aggregates more prone to destabilization. These findings highlight the molecular basis underlying FA antiamyloidogenic activity in AD.

Affiliations

Istituto Dei Composti Organo-Metallici, CNR, U.O. Pisa, Via G. Moruzzi, 1, 56124, Pisa, Italy; Istituto di Biofisica, CNR, U.O. Pisa, Via G. Moruzzi, 1, 56124, Pisa, Italy; Istituto Nazionale di Ottica, CNR, U.O. Pisa, Via G. Moruzzi, 1, 56124, Pisa, Italy

More information

The present work was supported by a Grant from the Italian Ministry of University and Scientific Research for Programs of Relevant National Interest (PRIN 2008-prot.20083Y34Y7) Development of a molecular strategy for the prevention of protein aggregation and fibrillogenesis: a biophysical approach.